抗悪性腫瘍薬の混合調製から投与,廃棄までを考慮した曝露防止器材(ケモセーフ®)の評価

Saved in:
Bibliographic Details
Published in医療薬学 Vol. 39; no. 2; pp. 117 - 124
Main Authors 苫米, 地敬, 中島, 克佳, 折山, 豊仁, 片岡, ヤス子, 柳原, 良次, 小見山, 智恵子, 鈴木, 洋史, 阿部, 敏秀
Format Journal Article
LanguageJapanese
Published 一般社団法人日本医療薬学会 2013
Online AccessGet full text
ISSN1346-342X
1882-1499
DOI10.5649/jjphcs.39.117

Cover

Author 小見山, 智恵子
苫米, 地敬
阿部, 敏秀
中島, 克佳
片岡, ヤス子
柳原, 良次
折山, 豊仁
鈴木, 洋史
Author_xml – sequence: 1
  fullname: 苫米, 地敬
  organization: 東京大学医学部附属病院薬剤部
– sequence: 1
  fullname: 中島, 克佳
  organization: 東京大学医学部附属病院薬剤部
– sequence: 1
  fullname: 折山, 豊仁
  organization: 東京大学医学部附属病院薬剤部
– sequence: 1
  fullname: 片岡, ヤス子
  organization: 東京大学医学部附属病院看護部
– sequence: 1
  fullname: 柳原, 良次
  organization: 東京大学医学部附属病院薬剤部
– sequence: 1
  fullname: 小見山, 智恵子
  organization: 東京大学医学部附属病院看護部
– sequence: 1
  fullname: 鈴木, 洋史
  organization: 東京大学医学部附属病院薬剤部
– sequence: 1
  fullname: 阿部, 敏秀
  organization: 東京大学医学部附属病院薬剤部
BookMark eNo9kElLw0AAhQep4Hr0Z6Rmss9NKW4geFHwFiaTqW2oC0kvHoQmsVBXRKgLKmJ7UKsW9KLQqOBfmXZMT_0LVipe3nvw4D34hkBibX2NAjAGxaSqKWjccTYyxEvKKAmh3gcGoWFIAlQQSnSzrGiCrEjLA2DU87KWKMoQalBFg2CL757yoMYLt3Hx4fvsID55ZH6dv762jkpx7TOuvjN_jwU7fLfcfDvsRPutRsir28z_YP4tC47jQsiLdeafMv-aX1y1L1_aZy_8qdI6v-NXR52oxIJnFlZY0GBhxMLyV70T7XQf4vty8-NmBPSncc6jo38-DJampxZTs8L8wsxcanJecKAhYgFpUEI2samqI1XRUVpTVUhEUaeyLlIKLUUnRCcSsSGyVAkbBFsioVSRJIvYFpKHwURv1_HyeIWaG252FbubJnbzWZKjZg-eKSNT-pUuwf-KZLBrOlj-AfhZmr4
ContentType Journal Article
Copyright 2013 日本医療薬学会
Copyright_xml – notice: 2013 日本医療薬学会
DOI 10.5649/jjphcs.39.117
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1882-1499
EndPage 124
ExternalDocumentID article_jjphcs_39_2_39_117_article_char_ja
GroupedDBID .LE
5GY
ABJNI
ALMA_UNASSIGNED_HOLDINGS
KQ8
MOJWN
RJT
ID FETCH-LOGICAL-j180a-96129dcde5795479f6551c007e370ee1b47cc7c2cd19b52a8cab0cee422bcdb93
ISSN 1346-342X
IngestDate Wed Sep 03 06:15:56 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j180a-96129dcde5795479f6551c007e370ee1b47cc7c2cd19b52a8cab0cee422bcdb93
OpenAccessLink https://www.jstage.jst.go.jp/article/jjphcs/39/2/39_117/_article/-char/ja
PageCount 8
ParticipantIDs jstage_primary_article_jjphcs_39_2_39_117_article_char_ja
PublicationCentury 2000
PublicationDate 2013
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – year: 2013
  text: 2013
PublicationDecade 2010
PublicationTitle 医療薬学
PublicationTitleAlternate 医療薬学
PublicationYear 2013
Publisher 一般社団法人日本医療薬学会
Publisher_xml – name: 一般社団法人日本医療薬学会
References 1) Stellman JM, Zoloth SR, Cancer chemotherapeutic agents as occupational hazards: A literature review, Cancer Invest, 1986, 4, 127-135.
3) American Society of Health System Pharmacists (ASHP), ASHP Guidelines on Handling Hazardous Drugs, Am J Health-Syst Phama, 2006, 63, 1172-1193.
15) Connor TH, Shults M and Fraser MP, Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 °C using a desiccator technique, Mutation Research, 2000, 470, 85-92.
2) Sorsa M, Hemminki K, Vainio H, Occupational exposure to anticancer drugs-potential and real hazards, Mutation Res, 1985, 154, 135-149.
11) Hama T, Aoyamai T, Shiraii T, Higuchii S, Yokokawa T, Sugimoto Y, Environmental Contamination due to Preparation of Cyclophosphamide and Exposure of Pharmacists to It, Jpn J Pharm Health Care Sci, 2009, 35, 693-700.
8) Yoshida J, Tei G, Mochizuki C, Masu Y, Koda S, Kumagai S, Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment, Ann Occup Hyg, 2009, 53, 153-160.
5) 石井範子, 佐々木真紀子, 長谷部真木子, 長岡真希子, 小稗文子, 杉山令子, 工藤由紀子, 秋田大学医学部保健学科紀要, 2009, 17, 23-30.
4) 注射剤・抗がん薬無菌調製ガイドライン, 日本病院薬剤師会学術第3小委員会編, 薬事日報社, 東京, 2009, pp.3-35.
10) Burgaz S, Karahalıl B, Bayrak P, Taskın L, Yavuzaslan F, Bokesoy I, Anzion RBM, Bos RP, Platin N, Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics, Mutation Res, 1999, 439, 97-104.
12) Yoshida J, Kosaka H, TomiokaK and Kumagai S, Genotoxic risks to nurses from contamination of the work environment with antineoplastic drugs in Japan, J Occup Health, 2006, 48, 517-522.
9) 西垣玲奈, 紺野英里, 杉安美紀, 米村雅人, 大塚知信, 渡邊協孝, 軍司剛宏, 戸塚ゆ加里, 若林敬二, 遠藤一司, 山本弘史, 抗がん薬による被曝防止を目的とした閉鎖式混合調製器具の有用性の検討, 日本病院薬剤師会雑誌, 2010, 46, 113-117.
14) 照井健太郎, 抗がん薬の安全な取り扱い, 月刊ナーシング, 2009, 30, 137-139.
16) 藪中裕美, 坂口史明, 小林由佳, 中西弘和, 注射用エンドキサンの揮発性に関する調査, 医療薬学, 2010, 36, 343-346.
7) Harrison BR, Peters BG, Bing MR, Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques, Am J Health Syst Pharm, 2006, 63, 1736-1744.
13) Sasaki M, Dakeishi M, Hoshi S, Ishii N, Murata K, Assessment of DNA Damage In Japanese Nurses Handling Antineoplastic Drugs by the Comet Assay, J Occup Health, 2008, 50, 7-12.
6) Connor TH, Anderson RW, Sessink PJ, Spivey SM, Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area, Am J Health Syst Pharm, 2002, 59, 68-72.
References_xml – reference: 1) Stellman JM, Zoloth SR, Cancer chemotherapeutic agents as occupational hazards: A literature review, Cancer Invest, 1986, 4, 127-135.
– reference: 2) Sorsa M, Hemminki K, Vainio H, Occupational exposure to anticancer drugs-potential and real hazards, Mutation Res, 1985, 154, 135-149.
– reference: 16) 藪中裕美, 坂口史明, 小林由佳, 中西弘和, 注射用エンドキサンの揮発性に関する調査, 医療薬学, 2010, 36, 343-346.
– reference: 5) 石井範子, 佐々木真紀子, 長谷部真木子, 長岡真希子, 小稗文子, 杉山令子, 工藤由紀子, 秋田大学医学部保健学科紀要, 2009, 17, 23-30.
– reference: 6) Connor TH, Anderson RW, Sessink PJ, Spivey SM, Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area, Am J Health Syst Pharm, 2002, 59, 68-72.
– reference: 13) Sasaki M, Dakeishi M, Hoshi S, Ishii N, Murata K, Assessment of DNA Damage In Japanese Nurses Handling Antineoplastic Drugs by the Comet Assay, J Occup Health, 2008, 50, 7-12.
– reference: 7) Harrison BR, Peters BG, Bing MR, Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques, Am J Health Syst Pharm, 2006, 63, 1736-1744.
– reference: 8) Yoshida J, Tei G, Mochizuki C, Masu Y, Koda S, Kumagai S, Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment, Ann Occup Hyg, 2009, 53, 153-160.
– reference: 11) Hama T, Aoyamai T, Shiraii T, Higuchii S, Yokokawa T, Sugimoto Y, Environmental Contamination due to Preparation of Cyclophosphamide and Exposure of Pharmacists to It, Jpn J Pharm Health Care Sci, 2009, 35, 693-700.
– reference: 12) Yoshida J, Kosaka H, TomiokaK and Kumagai S, Genotoxic risks to nurses from contamination of the work environment with antineoplastic drugs in Japan, J Occup Health, 2006, 48, 517-522.
– reference: 4) 注射剤・抗がん薬無菌調製ガイドライン, 日本病院薬剤師会学術第3小委員会編, 薬事日報社, 東京, 2009, pp.3-35.
– reference: 14) 照井健太郎, 抗がん薬の安全な取り扱い, 月刊ナーシング, 2009, 30, 137-139.
– reference: 9) 西垣玲奈, 紺野英里, 杉安美紀, 米村雅人, 大塚知信, 渡邊協孝, 軍司剛宏, 戸塚ゆ加里, 若林敬二, 遠藤一司, 山本弘史, 抗がん薬による被曝防止を目的とした閉鎖式混合調製器具の有用性の検討, 日本病院薬剤師会雑誌, 2010, 46, 113-117.
– reference: 10) Burgaz S, Karahalıl B, Bayrak P, Taskın L, Yavuzaslan F, Bokesoy I, Anzion RBM, Bos RP, Platin N, Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics, Mutation Res, 1999, 439, 97-104.
– reference: 15) Connor TH, Shults M and Fraser MP, Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 °C using a desiccator technique, Mutation Research, 2000, 470, 85-92.
– reference: 3) American Society of Health System Pharmacists (ASHP), ASHP Guidelines on Handling Hazardous Drugs, Am J Health-Syst Phama, 2006, 63, 1172-1193.
SSID ssib003116159
ssib002484604
ssib000871962
ssib060196744
ssj0069027
ssib005902156
ssib023157658
Score 1.9035501
SourceID jstage
SourceType Publisher
StartPage 117
Title 抗悪性腫瘍薬の混合調製から投与,廃棄までを考慮した曝露防止器材(ケモセーフ®)の評価
URI https://www.jstage.jst.go.jp/article/jjphcs/39/2/39_117/_article/-char/ja
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 医療薬学, 2013/02/10, Vol.39(2), pp.117-124
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3La9RAGA-lXryIT3yzB6enriaTSTJzzKQpoigKFXpbNtktsgct2h4UBHfXQn0iQrWiRawH3wW9KFgV_Fdi43rqv-D3zUy6qQi-IISPyW---R5J5vuGeVjWgcT2G24AX9oEdKdVNpE0q5zVvSqD_3GQuomjB_SPHfcPn2JHxr3xgcGbpVlL01PJwfTiL9eV_ItXoQz8iqtk_8Kza0yhAGjwL9zBw3D_Ix-T2Cc8JCJQBCVhqAibhFDCCfdIKEkcEAH0CJYIn4QRiV2IH0kYI1gGeMUeETbhHDHARI4qwiVyxIC5VAQlXBSNeiRmRAJn4DNKZER4hHykJNxFDFTnzFSXcdFoYPgIqiS0DRhFLTAiKIhRfCQkESCGICIikiqCKwKaGCEhVcILEnIFHkFFjDzctCUdRbgKrEukKZGRIUCdiCoZdF1RshKYQhT6xiR0ygE9tg6KS21ngcz7dvaUhGtjn0pjaXwCQkkXX3AlP3CwlfxQJerjlYGBB9oVhPULPJgLPcLQQdLt47VnuMI7eCk8RwoeIB684_TxASrKlf_BoqHBa1uxwlbCKKIPXC2GiPTaXvU5Fy-CrRTkSvUAGaDbPXRgqJws3cKKIV6oLsA8RUTGYL-zpaoeERGWelOX-VWX0XEdbOgyTOkgLRflLljvZ2V-NbTUnzp6Ya8JzRy93P7nXt_zGW6a22pNnk7PH4TfxFqtdRupm8-0pnE1V9Qo3gBcKx7hSsdaC9KtDTQIHJwhfPRkOVsJoL8qTUJgELyXRjNcB9On0m54AgPqtWgfMilI7vuTEHzcmkodPqEDRx_g6iyowmp6S2DU7tA63SBYbkHqWEw7VZHw2GZrk0lhK6HWZos10KpvtYZO6D3wLwxXxvpLOs8PV4YqJ_q741_YZl3Kr93LOy_yy097My-_zd_s3X2VtZfyd-9Wbs_2XnzuPfmYta9nnav5tbmv72-tLt9Y-dDNn1zJ2p-y9tOsc6d3uZvPLGXte1n7Uf5g4fvDt9_n3-avF1fuP8sXbq8uz2adN1l3Met8yLrLWXfuy9Lq8lVoofd87uunx9utU6PxWHS4as6AqbYcbterAjIw0UgbTS8QHgvEhA8pXgqJTRN6mGbTSViQpkFK04YjEo_WeVpPbAj8GaVJ2kiEu8MaPHP2THOnVeEJSzy7bttNv84SSFUEhyJI0Rq2SxM6scsS2qy1Sb3RT-3P35jd_1F3j7WRqjN2cFx3rzU4dW66uQ8ynalkv3r_fgDYniDk
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%8A%97%E6%82%AA%E6%80%A7%E8%85%AB%E7%98%8D%E8%96%AC%E3%81%AE%E6%B7%B7%E5%90%88%E8%AA%BF%E8%A3%BD%E3%81%8B%E3%82%89%E6%8A%95%E4%B8%8E%EF%BC%8C%E5%BB%83%E6%A3%84%E3%81%BE%E3%81%A7%E3%82%92%E8%80%83%E6%85%AE%E3%81%97%E3%81%9F%E6%9B%9D%E9%9C%B2%E9%98%B2%E6%AD%A2%E5%99%A8%E6%9D%90%EF%BC%88%E3%82%B1%E3%83%A2%E3%82%BB%E3%83%BC%E3%83%95%C2%AE%EF%BC%89%E3%81%AE%E8%A9%95%E4%BE%A1&rft.jtitle=%E5%8C%BB%E7%99%82%E8%96%AC%E5%AD%A6&rft.au=%E8%8B%AB%E7%B1%B3%2C+%E5%9C%B0%E6%95%AC&rft.au=%E4%B8%AD%E5%B3%B6%2C+%E5%85%8B%E4%BD%B3&rft.au=%E6%8A%98%E5%B1%B1%2C+%E8%B1%8A%E4%BB%81&rft.au=%E7%89%87%E5%B2%A1%2C+%E3%83%A4%E3%82%B9%E5%AD%90&rft.date=2013&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E6%97%A5%E6%9C%AC%E5%8C%BB%E7%99%82%E8%96%AC%E5%AD%A6%E4%BC%9A&rft.issn=1346-342X&rft.eissn=1882-1499&rft.volume=39&rft.issue=2&rft.spage=117&rft.epage=124&rft_id=info:doi/10.5649%2Fjjphcs.39.117&rft.externalDocID=article_jjphcs_39_2_39_117_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-342X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-342X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-342X&client=summon